Navigation Links
Second-generation CT scanner substantially reduces radiation exposure
Date:1/31/2013

OAK BROOK, Ill. (January 31, 2013) Researchers using a newly approved advanced computed tomography (CT) system were able to significantly reduce radiation exposure in patients undergoing coronary CT angiography (CCTA), according to a new study published online in the journal Radiology.

"Radiation exposure during diagnostic imaging is a substantial public concern," said Marcus Y. Chen, M.D., lead author of the study from the advanced cardiovascular imaging laboratory at the National Institutes of Health in Bethesda, Md. "Minimizing radiation exposure while maintaining diagnostic-quality scans is clearly feasible with this new second-generation 320detector row CT scanner."

CCTA is a valuable noninvasive imaging exam with high diagnostic accuracy. The exam is particularly effective and safe for the exclusion of significant coronary artery disease in patients arriving at the emergency department with acute chest pain. However, the clinical benefit of CCTA has been tempered by concerns of potential future cancer risk from the radiation exposure. Technologic advances have evolved to allow radiologists to not only reduce radiation exposure to the patient but also to improve image acquisition.

This study represents the initial coronary angiography results obtained with a prototype 320detector row CT system recently approved by the U.S. Food and Drug Administration. The new system holds several technical advantages over its first-generation counterpart, including a gantry rotation time of 275 milliseconds, wide volume coverage, iterative reconstruction, automated exposure control, and a larger x-ray power generator.

For the study, Dr. Chen and colleagues performed contrastenhanced CCTA with a second-generation 320-slice CT system on 107 adult patients (mean age, 55.4) and compared radiation exposure and image quality to those of CCTA exams previously performed on 100 patients using a first-generation 320-slice scanner.

Effective radiation dose was estimated by multiplying the dose-length producta calculation of the radiation dose for a series of scans or entire examinationby an effective dose conversion factor and reported with size-specific dose estimates (SSDEs). Image quality was evaluated by two independent readers.

The median radiation dose was 0.93 millisieverts (mSv) with the second-generation unit and 2.67 mSv with the first-generation unit. The median SSDE was 6.0 milligray (mGy) with the second-generation unit and 13.2 mGy with the first-generation unit. Overall, the radiation dose was less than 0.5 mSv for 23 of the 107 CT angiography examinations (21.5 percent), less than 1 mSv for 58 (54.2 percent), and less than 4 mSv for 103 (96.3 percent). All studies were of diagnostic quality, with most having excellent image quality.

"The second-generation CT scanner provided excellent image quality over a wide range of body sizes and heart rates at low radiation doses," Dr. Chen said. "The low dose achieved during CT angiography could be used to minimize overall radiation dose to the patient or to enable additional types of imaging within reasonable radiation doses."


'/>"/>

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America
Source:Eurekalert

Related medicine news :

1. A scanner for hereditary defects
2. Into the magnetic resonance scanner with a cuddly toy
3. Frequent MRI Scanner Exposure Might Affect Memory: Study
4. Bariatric surgery substantially reduces the risk of diabetes
5. Physical health problems substantially increase use of mental health services, study shows
6. Marriage reduces the risk of heart attack in both men and women and at all ages
7. Emotional stress reduces effectiveness of prostate cancer therapies in animal model
8. Exposure to COI policies during residency reduces rate of brand antidepressant prescriptions
9. Federal Safe Routes to School program reduces child injuries by more than 40 percent in New York City
10. Immunotherapy reduces allergic patients sensitivity to peanuts
11. Weekly dose reduces targeted drugs side effects, but not its activity against ALL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... ... Stern Environmental Group , of Secaucus, New Jersey, working in conjunction ... Real Time Monitoring (RTM) Device. Stern Environmental Group will sell the first monitoring ... use in dormitories, shelters, and nursing homes for real time bedbug monitoring in May ...
(Date:5/24/2016)... ... 2016 , ... Sterling Global Products is launching a Kickstarter campaign focused on ... dispenser. The campaign kick-off video is located via this link https://youtu.be/WsO4qz2odco . The ... is to raise $1,000 per day for a total of $25,000. The funds will ...
(Date:5/24/2016)... ... May 24, 2016 , ... To better understand the impact of lung cancer ... gender differences in lung cancer. Today, the Lung Association announced Sharad Goyal, MD , ... Award, funded by the American Lung Association’s LUNG FORCE initiative, which raises awareness of ...
(Date:5/24/2016)... ... May 24, 2016 , ... i2i, ... identity and website at its “Transforming Outcomes” User Conference in Las Vegas on ... i2i’s ongoing success to set the market standard for meaningful population health management. ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... enabled solutions and managed services today announced a strategic partnership with Five9 ... center market. , Altura, one of Avaya’s largest Platinum Business Partners, is ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)...   , Study met both ... superiority in , Excellent plus Good ... of the ascending colon   , ... today announced new positive data from the phase III MORA study ... 2 litre PEG with ascorbate. The study met both primary endpoints ...
(Date:5/24/2016)... 2016  NxStage Medical, Inc. (Nasdaq: NXTM ... renal care, today announced that Jeffrey H. Burbank ... following schedule of investor conferences. Where applicable, a webcast ... http://ir.nxstage.com/ .   ... NY           Friday, June 10, 2016 1:30 p.m. ET ...
(Date:5/24/2016)... The innovator of COMBO ... s first dual therapy stent, introduces catheters for ... OrbusNeich, a global company specializing in the provision of ... products to treat peripheral artery disease. The JADE™ and ... for lower limb and arteriovenous (AV) fistula intervention. ...
Breaking Medicine Technology: